Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

被引：0
|
作者：
F Pauly
K Fjordén
S Leppä
H Holte
M Björkholm
Ø Fluge
L Møller Pedersen
M Eriksson
A Isinger-Ekstrand
C A K Borrebaeck
M Jerkeman
C Wingren
机构：
[1] Lund University,Department of Immunotechnology
[2] CREATE Health,Department of Oncology
[3] Lund University,Department of Oncology
[4] Lund University,Department of Oncology
[5] Skåne University Hospital,Department of Medicine
[6] Helsinki University Hospital,Department of Oncology
[7] Oslo University Hospital,Department of Hematology
[8] Karolinska University Hospital,undefined
[9] Haukeland University Hospital,undefined
[10] Roskilde Hospital,undefined
来源：
Blood Cancer Journal | 2016年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e501 / e501
相关论文
共 50 条
  • [41] Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
    Charlott Mörth
    Amal Abu Sabaa
    Eva Freyhult
    Christina Christersson
    Jamileh Hashemi
    Nashmil Hashemi
    Masood Kamali-Moghaddam
    Daniel Molin
    Martin Höglund
    Anna Eriksson
    Gunilla Enblad
    Cardio-Oncology, 7
  • [42] Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
    Morth, Charlott
    Abu Sabaa, Amal
    Freyhult, Eva
    Christersson, Christina
    Hashemi, Jamileh
    Hashemi, Nashmil
    Kamali-Moghaddam, Masood
    Molin, Daniel
    Hoglund, Martin
    Eriksson, Anna
    Enblad, Gunilla
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [43] Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients
    Zhao, Jinrong
    Zhang, Yan
    Wang, Wei
    Zhang, Wei
    Zhou, Dao-bin
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [44] Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies
    Savage, Kerry J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 578 - 586
  • [45] Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA
    Mytelka, Daniel S.
    Li, Li
    Stafkey-Mailey, Dana
    Liepa, Astra M.
    Hess, Lisa M.
    Farrelly, Eileen
    Eaddy, Michael
    HEMATOLOGY, 2015, 20 (08) : 442 - 448
  • [46] Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma Reply
    Chiappella, Annalisa
    Martelli, Maurizio
    Evangelista, Andrea
    Vitolo, Umberto
    LANCET ONCOLOGY, 2017, 18 (10): : E558 - E558
  • [47] Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group
    Wada, Naoki
    Zaki, Mona A. A.
    Hori, Yumiko
    Hashimoto, Koji
    Tsukaguchi, Machiko
    Tatsumi, Yoichi
    Ishikawa, Jun
    Tominaga, Nobuhiko
    Sakoda, Hiroto
    Take, Hironori
    Tsudo, Mitsuru
    Kuwayama, Maki
    Morii, Eiichi
    Aozasa, Katsuyuki
    HISTOPATHOLOGY, 2012, 60 (02) : 313 - 319
  • [48] Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group
    Shiozawa, Eisuke
    Takimoto, Masafumi
    Makino, Reiko
    Adachi, Daisuke
    Saito, Bungo
    Yamochi-Onizuka, Toshiko
    Yamochi, Tadanori
    Shimozuma, Junko
    Maeda, Takashi
    Kohno, Yohko
    Kawakami, Keiichiro
    Nakamaki, Tsuyoshi
    Tomoyasu, Shigeru
    Shiokawa, Akira
    Ota, Hidekazu
    LEUKEMIA RESEARCH, 2006, 30 (07) : 859 - 867
  • [49] Diffuse large B-cell lymphoma showing an interfollicular pattern of proliferation: a study of the Osaka Lymphoma Study Group
    Yamauchi, A.
    Ikeda, J.
    Nakamichi, I.
    Kohara, M.
    Fukuhara, S.
    Hino, M.
    Kanakura, Y.
    Ogawa, H.
    Sugiyama, H.
    Kanamaru, A.
    Aozasa, K.
    HISTOPATHOLOGY, 2008, 52 (06) : 731 - 737
  • [50] Early detection of patients with poor risk diffuse large B-cell lymphoma
    Sehn, Laurie H.
    LEUKEMIA & LYMPHOMA, 2009, 50 (11) : 1744 - 1747
12345